Premature ventricular contraction other diagnostic studies: Difference between revisions
Jump to navigation
Jump to search
Homa Najafi (talk | contribs) (/* 2017 AHA/ACC/HRS Guideline for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death (DO NOT EDIT){{cite journal|last1=Al-Khatib|first1=Sana M.|last2=Stevenson|first2=William G.|last3=Ackerman|first3=Michael...) |
Homa Najafi (talk | contribs) |
||
| Line 54: | Line 54: | ||
| colspan="1" style="text-align:center; background:LightCoral"|[[ESC guidelines classification scheme#Classification of Recommendations|Class III]] | | colspan="1" style="text-align:center; background:LightCoral"|[[ESC guidelines classification scheme#Classification of Recommendations|Class III]] | ||
|- | |- | ||
|bgcolor="LightCoral" |<nowiki></nowiki> '''1.''' In patients who meet criteria for ICD implantation, an electrophysiological study for the sole reason of inducing VA is not | |bgcolor="LightCoral" |<nowiki></nowiki> '''1.''' In patients who meet criteria for ICD implantation, an electrophysiological study for the sole reason of inducing VA is not indicated for risk stratification''([[ACC AHA Guidelines Classification Scheme#Level of Evidence|Level of Evidence: B-R]])''.<ref name="BardyLee2005">{{cite journal|last1=Bardy|first1=Gust H.|last2=Lee|first2=Kerry L.|last3=Mark|first3=Daniel B.|last4=Poole|first4=Jeanne E.|last5=Packer|first5=Douglas L.|last6=Boineau|first6=Robin|last7=Domanski|first7=Michael|last8=Troutman|first8=Charles|last9=Anderson|first9=Jill|last10=Johnson|first10=George|last11=McNulty|first11=Steven E.|last12=Clapp-Channing|first12=Nancy|last13=Davidson-Ray|first13=Linda D.|last14=Fraulo|first14=Elizabeth S.|last15=Fishbein|first15=Daniel P.|last16=Luceri|first16=Richard M.|last17=Ip|first17=John H.|title=Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure|journal=New England Journal of Medicine|volume=352|issue=3|year=2005|pages=225–237|issn=0028-4793|doi=10.1056/NEJMoa043399}}</ref><ref name="BuxtonLee1999">{{cite journal|last1=Buxton|first1=Alfred E.|last2=Lee|first2=Kerry L.|last3=Fisher|first3=John D.|last4=Josephson|first4=Mark E.|last5=Prystowsky|first5=Eric N.|last6=Hafley|first6=Gail|title=A Randomized Study of the Prevention of Sudden Death in Patients with Coronary Artery Disease|journal=New England Journal of Medicine|volume=341|issue=25|year=1999|pages=1882–1890|issn=0028-4793|doi=10.1056/NEJM199912163412503}}</ref><ref name="MossHall1996">{{cite journal|last1=Moss|first1=Arthur J.|last2=Hall|first2=W. Jackson|last3=Cannom|first3=David S.|last4=Daubert|first4=James P.|last5=Higgins|first5=Steven L.|last6=Klein|first6=Helmut|last7=Levine|first7=Joseph H.|last8=Saksena|first8=Sanjeev|last9=Waldo|first9=Albert L.|last10=Wilber|first10=David|last11=Brown|first11=Mary W.|last12=Heo|first12=Moonseong|title=Improved Survival with an Implanted Defibrillator in Patients with Coronary Disease at High Risk for Ventricular Arrhythmia|journal=New England Journal of Medicine|volume=335|issue=26|year=1996|pages=1933–1940|issn=0028-4793|doi=10.1056/NEJM199612263352601}}</ref><ref name="MossZareba2002">{{cite journal|last1=Moss|first1=Arthur J.|last2=Zareba|first2=Wojciech|last3=Hall|first3=W. Jackson|last4=Klein|first4=Helmut|last5=Wilber|first5=David J.|last6=Cannom|first6=David S.|last7=Daubert|first7=James P.|last8=Higgins|first8=Steven L.|last9=Brown|first9=Mary W.|last10=Andrews|first10=Mark L.|title=Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection Fraction|journal=New England Journal of Medicine|volume=346|issue=12|year=2002|pages=877–883|issn=0028-4793|doi=10.1056/NEJMoa013474}}</ref> | ||
indicated for risk stratification''([[ACC AHA Guidelines Classification Scheme#Level of Evidence|Level of Evidence: B-R]])''. | |||
'''2.''' An electrophysiological study is not recommended for risk stratification for VA in the setting of long QT syndrome, catecholaminergic polymorphic ventricular tachycardia, short QT syndrome, or early repolarization syndromes''([[ACC AHA Guidelines Classification Scheme#Level of Evidence|Level of Evidence: B-R]])''. | '''2.''' An electrophysiological study is not recommended for risk stratification for VA in the setting of long QT syndrome, catecholaminergic polymorphic ventricular tachycardia, short QT syndrome, or early repolarization syndromes''([[ACC AHA Guidelines Classification Scheme#Level of Evidence|Level of Evidence: B-R]])''. | ||
Revision as of 21:13, 21 April 2020
|
Premature ventricular contraction Microchapters |
|
Differentiating Premature Ventricular Contraction from other Disorders |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Premature ventricular contraction other diagnostic studies On the Web |
|
FDA on Premature ventricular contraction other diagnostic studies |
|
CDC onPremature ventricular contraction other diagnostic studies |
|
Premature ventricular contraction other diagnostic studies in the news |
|
Blogs on Premature ventricular contraction other diagnostic studies |
|
to Hospitals Treating Premature ventricular contraction other diagnostic studies |
|
Risk calculators and risk factors for Premature ventricular contraction other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2]
Overview
There are no other diagnostic studies associated with [disease name].
OR
[Diagnostic study] may be helpful in the diagnosis of [disease name]. Findings suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].
OR
Other diagnostic studies for [disease name] include [diagnostic study 1], which demonstrates [finding 1], [finding 2], and [finding 3], and [diagnostic study 2], which demonstrates [finding 1], [finding 2], and [finding 3].
Other Diagnostic Studies
There are no other diagnostic studies associated with [disease name].
OR
[Diagnostic study] may be helpful in the diagnosis of [disease name]. Findings suggestive of/diagnostic of [disease name] include:
- [Finding 1]
- [Finding 2]
- [Finding 3]
OR
Other diagnostic studies for [disease name] include:
- [Diagnostic study 1], which demonstrates:
- [Finding 1]
- [Finding 2]
- [Finding 3]
- [Diagnostic study 2], which demonstrates:
- [Finding 1]
- [Finding 2]
- [Finding 3]
2017 AHA/ACC/HRS Guideline for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death (DO NOT EDIT)[1]
Recommendations for Electrophysiological Study
| Class IIa |
| 1. In patients with ischemic cardiomyopathy, NICM, or adult congenital heart disease who have syncope or other VA symptoms and who do not meet indications for a primary prevention ICD, an electrophysiological study can be useful for assessing the risk of sustained VT (Level of Evidence: B-R).[2][3][4][5][6][7][8] |
| Class III |
| 1. In patients who meet criteria for ICD implantation, an electrophysiological study for the sole reason of inducing VA is not indicated for risk stratification(Level of Evidence: B-R).[9][10][11][12]
2. An electrophysiological study is not recommended for risk stratification for VA in the setting of long QT syndrome, catecholaminergic polymorphic ventricular tachycardia, short QT syndrome, or early repolarization syndromes(Level of Evidence: B-R).
|
References
- ↑ Al-Khatib, Sana M.; Stevenson, William G.; Ackerman, Michael J.; Bryant, William J.; Callans, David J.; Curtis, Anne B.; Deal, Barbara J.; Dickfeld, Timm; Field, Michael E.; Fonarow, Gregg C.; Gillis, Anne M.; Granger, Christopher B.; Hammill, Stephen C.; Hlatky, Mark A.; Joglar, José A.; Kay, G. Neal; Matlock, Daniel D.; Myerburg, Robert J.; Page, Richard L. (2018). "2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death". Circulation. 138 (13). doi:10.1161/CIR.0000000000000549. ISSN 0009-7322.
- ↑ Buxton, Alfred E.; Lee, Kerry L.; DiCarlo, Lorenzo; Gold, Michael R.; Greer, G. Stephen; Prystowsky, Eric N.; O'Toole, Michael F.; Tang, Anthony; Fisher, John D.; Coromilas, James; Talajic, Mario; Hafley, Gail (2000). "Electrophysiologic Testing to Identify Patients with Coronary Artery Disease Who Are at Risk for Sudden Death". New England Journal of Medicine. 342 (26): 1937–1945. doi:10.1056/NEJM200006293422602. ISSN 0028-4793.
- ↑ Buxton, Alfred E.; Lee, Kerry L.; Hafley, Gail E.; Wyse, D. George; Fisher, John D.; Lehmann, Michael H.; Pires, Luis A.; Gold, Michael R.; Packer, Douglas L.; Josephson, Mark E.; Prystowsky, Eric N.; Talajic, Mario R. (2002). "Relation of Ejection Fraction and Inducible Ventricular Tachycardia to Mode of Death in Patients With Coronary Artery Disease". Circulation. 106 (19): 2466–2472. doi:10.1161/01.CIR.0000037224.15873.83. ISSN 0009-7322.
- ↑ Costantini, Otto; Hohnloser, Stefan H.; Kirk, Malcolm M.; Lerman, Bruce B.; Baker, James H.; Sethuraman, Barathi; Dettmer, Mary M.; Rosenbaum, David S. (2009). "The ABCD (Alternans Before Cardioverter Defibrillator) Trial". Journal of the American College of Cardiology. 53 (6): 471–479. doi:10.1016/j.jacc.2008.08.077. ISSN 0735-1097.
- ↑ Bourke, John P.; Richards, David A.B.; Ross, David L.; Wallace, Elizabeth M.; McGuire, Mark A.; Uther, John B. (1991). "Routine programmed electrical stimulation in survivors of acute myocardial infarction for prediction of spontaneous ventricular tachyarrhythmias during follow-up: Results, optimal stimulation protocol and cost-effective screening". Journal of the American College of Cardiology. 18 (3): 780–788. doi:10.1016/0735-1097(91)90802-G. ISSN 0735-1097.
- ↑ Schmitt, Claus; Barthel, Petra; Ndrepepa, Gjin; Schreieck, Jürgen; Plewan, Andreas; Schömig, A; Schmidt, Georg (2001). "Value of programmed ventricular stimulation for prophylactic internal cardioverter-defibrillator implantation in postinfarction patients preselected by noninvasive risk stratifiers". Journal of the American College of Cardiology. 37 (7): 1901–1907. doi:10.1016/S0735-1097(01)01246-3. ISSN 0735-1097.
- ↑ Bailey, James J; Berson, Alan S; Handelsman, Harry; Hodges, Morrison (2001). "Utility of current risk stratification tests for predicting major arrhythmic events after myocardial infarction". Journal of the American College of Cardiology. 38 (7): 1902–1911. doi:10.1016/S0735-1097(01)01667-9. ISSN 0735-1097.
- ↑ Hilfiker, Gabriela (2015). "Utility of electrophysiological studies to predict arrhythmic events". World Journal of Cardiology. 7 (6): 344. doi:10.4330/wjc.v7.i6.344. ISSN 1949-8462.
- ↑ Bardy, Gust H.; Lee, Kerry L.; Mark, Daniel B.; Poole, Jeanne E.; Packer, Douglas L.; Boineau, Robin; Domanski, Michael; Troutman, Charles; Anderson, Jill; Johnson, George; McNulty, Steven E.; Clapp-Channing, Nancy; Davidson-Ray, Linda D.; Fraulo, Elizabeth S.; Fishbein, Daniel P.; Luceri, Richard M.; Ip, John H. (2005). "Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure". New England Journal of Medicine. 352 (3): 225–237. doi:10.1056/NEJMoa043399. ISSN 0028-4793.
- ↑ Buxton, Alfred E.; Lee, Kerry L.; Fisher, John D.; Josephson, Mark E.; Prystowsky, Eric N.; Hafley, Gail (1999). "A Randomized Study of the Prevention of Sudden Death in Patients with Coronary Artery Disease". New England Journal of Medicine. 341 (25): 1882–1890. doi:10.1056/NEJM199912163412503. ISSN 0028-4793.
- ↑ Moss, Arthur J.; Hall, W. Jackson; Cannom, David S.; Daubert, James P.; Higgins, Steven L.; Klein, Helmut; Levine, Joseph H.; Saksena, Sanjeev; Waldo, Albert L.; Wilber, David; Brown, Mary W.; Heo, Moonseong (1996). "Improved Survival with an Implanted Defibrillator in Patients with Coronary Disease at High Risk for Ventricular Arrhythmia". New England Journal of Medicine. 335 (26): 1933–1940. doi:10.1056/NEJM199612263352601. ISSN 0028-4793.
- ↑ Moss, Arthur J.; Zareba, Wojciech; Hall, W. Jackson; Klein, Helmut; Wilber, David J.; Cannom, David S.; Daubert, James P.; Higgins, Steven L.; Brown, Mary W.; Andrews, Mark L. (2002). "Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection Fraction". New England Journal of Medicine. 346 (12): 877–883. doi:10.1056/NEJMoa013474. ISSN 0028-4793.